DarioHealth Corp (DRIO)

Currency in USD
1.320
-0.120(-8.33%)
Closed·
1.600+0.280(+21.21%)
·
Unusual Post-Market activity
DRIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2601.650
52 wk Range
1.09014.490
Key Statistics
Prev. Close
1.32
Open
1.41
Day's Range
1.26-1.65
52 wk Range
1.09-14.49
Volume
28.21K
Average Vol. (3m)
48.12K
1-Year Change
-90.507%
Book Value / Share
7.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DRIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.000
Upside
+506.06%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

DarioHealth Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.000
(+506.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy5.00+278.79%10.00MaintainNov 13, 2026
BTIG
Buy6.00+354.55%-New CoverageOct 27, 2026
Alliance Global Partners
Buy12.00+809.09%-New CoverageAug 19, 2026
Stifel
Buy10.00+657.58%16.00MaintainMar 20, 2026

DarioHealth Corp Earnings Call Summary for Q3/2026

  • DarioHealth posted Q3 2026 adjusted EPS of $0.73 vs. analyst forecast of -$1.11 loss; revenue rose 6% YoY to $5.31M, topping estimates.
  • Operating expenses fell 10% YoY while operating loss narrowed to $8.0M from $10.5M; company maintains 80% non-GAAP B2B2C gross margin for 11th quarter.
  • Firm holds $13.1M in contracted ARR, expects revenue acceleration in late 2026 into 2027, with break-even targeted for 2028.
  • Over 80% of recurring revenue now multi-condition; 75% of new accounts from channel partners, lowering customer acquisition costs.
  • Shares rose 5.9% premarket but remain near 52-week lows; new Dario Women product launches Jan 2027 with two early adopters.
Last Updated: 11/12/2026, 09:50 AM
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
0.73 / -1.11
Revenue / Forecast
5.31M / 5.19M
EPS Revisions
Last 90 days

DRIO Income Statement

Compare DRIO to Peers and Sector

Metrics to compare
DRIO
Peers
Sector
Relationship
P/E Ratio
−0.4x−0.3x−0.2x
PEG Ratio
−0.010.000.00
Price / Book
0.2x0.7x2.6x
Price / LTM Sales
0.7x1.3x2.6x
Upside (Analyst Target)
-35.3%76.9%
Fair Value Upside
Unlock38.3%14.9%Unlock

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
199.86K2.04%291.79K
Other Institutional Investors
820.07K8.37%1.20M
Public Companies & Retail Investors
8.78M89.59%12.82M
Total
9.8M100.00%14.31M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nantahala Capital Management, LLC6.23%610,691892
Solid Financial Llc1.09%106,982156

People Also Watch

54.430
LQDA
-3.88%
1.950
FRMI
-5.34%
122.73
MHO
+1.11%
110.54
AGYS
-2.04%
18.51
LKQ
-1.59%

FAQ

What Is the DarioHealth (DRIO) Stock Price Today?

The DarioHealth stock price today is 1.320 USD.

What Stock Exchange Does DarioHealth Trade On?

DarioHealth is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for DarioHealth?

The stock symbol for DarioHealth is "DRIO."

What Is the DarioHealth Market Cap?

As of today, DarioHealth market cap is 16.250M USD.

What Is DarioHealth's Earnings Per Share (TTM)?

The DarioHealth EPS (TTM) is -4.28.

When Is the Next DarioHealth Earnings Date?

DarioHealth will release its next earnings report on Mar 10, 2027.

From a Technical Analysis Perspective, Is DRIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has DarioHealth Stock Split?

DarioHealth has split 4 times.

How Many Employees Does DarioHealth Have?

DarioHealth has 163 employees.

What is the current trading status of DarioHealth (DRIO)?

As of Nov 21, 2026, DarioHealth (DRIO) is trading at a price of 1.320 USD, with a previous close of 1.320 USD. The stock has fluctuated within a day range of 1.260 USD to 1.650 USD, while its 52-week range spans from 1.090 USD to 14.490 USD.

What Is DarioHealth (DRIO) Price Target According to Analysts?

The average 12-month price target for DarioHealth is 8.000 USD, with a high estimate of 11 USD and a low estimate of 5 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +506.06% Upside potential.

What Is the DRIO Premarket Price?

DRIO's last pre-market stock price is 1.579 USD. The pre-market share volume is 120.000, and the stock has decreased by 0.139, or 9.650%.

What Is the DRIO After Hours Price?

DRIO's last after hours stock price is 1.600 USD, the stock has decreased by 0.280, or 21.210%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.